With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Identifying Rare Genetic Variants Involved in High Risk Pediatric Leukemia Via Pooled Sequencing||Washington University / Todd Druley, MD, PhD||'A' Award Grants||2009||Missouri|
|Investigating the role of lin-28 in germ cell tumorigenesis||Boston Children's Hospital / George Daley||Innovation Grants||2009||Massachusetts|
|Epigenetic manipulation of leukemia.||Cincinnati Children's Hospital Medical Center / H. Leighton Grimes||Innovation Grants||2009||Ohio|
|Metabolic control of p53 activation in T-ALL.||Duke University / Jeffrey Rathmell||Innovation Grants||2009||North Carolina|
|Modeling anaplastic medulloblastoma using cerebellar stem cells||Duke University / Robert Wechsler-Reya, PhD||Innovation Grants||2009||North Carolina|
|Targeted regulation of acetylation as novel therapy for Ewing sarcoma.||Georgetown University / Jeffrey Toretsky||Innovation Grants||2009||District of Columbia|
|Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma.||Huntsman Cancer Institute / Stephen Lessnick||Innovation Grants||2009||Utah|
|Linking mitogenic sonic hedgehog signaling to the oncogene Yap 1 in neural stem/progenitor cells and medulloblastoma.||Memorial Sloan-Kettering Cancer Center / Anna Kenney, PhD||Innovation Grants||2009||New York|
|Pharmacogenomics of childhood AML susceptibility and treatment response.||Children's Hospital of Philadelphia / Richard Aplenc||Innovation Grants||2009||Pennsylvania|
|BH3 profiling to define therapy resistance classes in neuroblastoma.||Children's Hospital of Philadelphia / Michael Hogarty||Innovation Grants||2009||Pennsylvania|